Antigenicity and immunogenicity of Plasmodium vivax merozoite surface protein-3
A recent clinical trial in African children demonstrated the potential utility of merozoite surface protein (MSP)-3 as a vaccine against Plasmodium falciparum malaria. The present study evaluated the use of Plasmodium vivax MSP-3 (PvMSP-3) as a target antigen in vaccine formulations against malaria...
Hlavní autoři: | Bitencourt, A, Vicentin, E, Jimenez, M, Ricci, R, Leite, J, Costa, F, Ferreira, L, Russell, B, Nosten, F, Rénia, L, Galinski, MR, Barnwell, J, Rodrigues, M, Soares, I |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
Public Library of Science
2013
|
Podobné jednotky
-
Antigenicity and immunogenicity of Plasmodium vivax merozoite surface protein-3.
Autor: Amanda R Bitencourt, a další
Vydáno: (2013-01-01) -
<it>Plasmodium vivax</it>: who cares?
Autor: Barnwell John W, a další
Vydáno: (2008-12-01) -
Plasmodium vivax merozoite surface protein-3 (PvMSP3): expression of an 11 member multigene family in blood-stage parasites.
Autor: Jianlin Jiang, a další
Vydáno: (2013-01-01) -
Plasmodium vivax merozoite surface protein 1 paralog as a mediator of parasite adherence to reticulocytes
Autor: Han, J, a další
Vydáno: (2018) -
Invasion-inhibitory antibodies elicited by immunization with Plasmodium vivax apical membrane antigen-1 expressed in Pichia pastoris yeast.
Autor: Vicentin, E, a další
Vydáno: (2014)